Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Psychiatr Serv ; 68(4): 408-410, 2017 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-27974000

RESUMEN

OBJECTIVE: This study compared characteristics of visits to emergency rooms (ERs) for mental and substance use disorders and for physical health conditions to establish a baseline against which to measure changes after full implementation of the Affordable Care Act (ACA) and parity legislation. METHODS: The retrospective, cross-sectional analysis fit a logistic regression model to pooled data comprising 193,526 observations from National Hospital Ambulatory Medical Care Survey (NHAMCS) data from 2005 to 2011. RESULTS: ER visits for mental or substance use disorders increased from 27.9 per 1,000 ER visits in 2005 to 35.1 in 2011. Homeless persons and nursing home residents had the highest rates of such visits-173.7 and 95.2 per 1,000 ER visits, respectively, in 2011. CONCLUSIONS: Understanding differences in profiles of ER visits on the basis of the reason for the visit can inform the design of more cost-effective policies to guide ER intake, after further implementation of the ACA and parity legislation.


Asunto(s)
Servicio de Urgencia en Hospital/estadística & datos numéricos , Personas con Mala Vivienda/estadística & datos numéricos , Trastornos Mentales/terapia , Casas de Salud/estadística & datos numéricos , Adolescente , Adulto , Estudios Transversales , Femenino , Encuestas de Atención de la Salud/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Patient Protection and Affordable Care Act/legislación & jurisprudencia , Estudios Retrospectivos , Trastornos Relacionados con Sustancias/terapia , Estados Unidos , Adulto Joven
2.
Health Econ ; 25(5): 606-19, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-25903420

RESUMEN

Prescription drugs are the third largest component of U.S. healthcare expenditures. The 2006 Medicare Part D and the 2010 Affordable Care Act are catalysts for further growths in utilization becuase of insurance expansion effects. This research investigating the determinants of prescription drug utilization is timely, methodologically novel, and policy relevant. Differences in population health status, access to care, socioeconomics, demographics, and variations in per capita number of scripts filled at retail pharmacies across the U.S.A. justify fitting separate econometric models to county data of the states partitioned into low, medium, and high prescription drug users. Given the skewed distribution of per capita number of filled prescriptions (response variable), we fit the variance stabilizing Box-Cox power transformation regression models to 2011 county level data for investigating the correlates of prescription drug utilization separately for low, medium, and high utilization states. Maximum likelihood regression parameter estimates, including the optimal Box-Cox λ power transformations, differ across high (λ = 0.214), medium (λ = 0.942), and low (λ = 0.302) prescription drug utilization models. The estimated income elasticities of -0.634, 0.031, and -0.532 in high, medium, and low utilization models suggest that the economic behavior of prescriptions is not invariant across different utilization levels.


Asunto(s)
Prescripciones de Medicamentos/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Medicamentos bajo Prescripción/uso terapéutico , Prescripciones de Medicamentos/economía , Gastos en Salud , Humanos , Medicare Part D/economía , Modelos Estadísticos , Medicamentos bajo Prescripción/economía , Honorarios por Prescripción de Medicamentos , Factores Socioeconómicos , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...